n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with glyburide in 4 studies
Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (glyburide) | Trials (glyburide) | Recent Studies (post-2010) (glyburide) |
---|---|---|---|---|---|
214 | 5 | 58 | 6,554 | 620 | 1,344 |
Protein | Taxonomy | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) | glyburide (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 0.22 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 5.7 | |
Bile salt export pump | Homo sapiens (human) | 5.5333 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 1.602 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.0043 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.1121 | |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 10 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J | 1 |
Liang, BT | 1 |
4 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and glyburide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Polypharmacology of N
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3 | 2017 |
Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection.
Topics: Adenosine; Animals; Cells, Cultured; Chick Embryo; Enzyme Activation; Glyburide; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardium; Pinacidil; Potassium Channels; Protein Kinase C; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate | 1998 |